• Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

  • May 29 2024
  • Length: 23 mins
  • Podcast

Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

  • Summary

  • In this podcast recorded in early May, James Cave (Editor-in-Chief) and David Phizackerley (Deputy Editor) talk about the June 2024 issue of DTB. They discuss the editorial that highlights changes to the use of gonadal and fetal shielding for diagnostic imaging (see link). They review the results of a study that assessed the benefit of antibiotics for treating acute sinusitis in children aged 2-11 years. The main article considers the evidence for ritlecitinib, a Janus kinase enzyme inhibitor that is licensed for the treatment of severe alopecia areata in adults and adolescents aged ≥12 years. They begin the podcast by discussing newspaper headlines generated by an international conference on obesity. Link https://www.bir.org.uk/education-and-events/patient-shielding-guidance.aspx Please subscribe to the DTB podcast to get episodes automatically downloaded to your mobile device and computer. Also, please consider leaving us a review or a comment on the DTB Podcast iTunes podcast page (https://podcasts.apple.com/gb/podcast/dtb-podcast/id307773309). If you want to contact us please email dtb@bmj.com. Thank you for listening.
    Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about Diagnostic imaging and shielding, sinusitis, antibiotics and coloured snot, ritlecitinib

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.